Related Experiment Video
Updated: Jun 5, 2025

Intratracheal Instillation of Stem Cells in Term Neonatal Rats
Published on: May 4, 2020
Predictive analytics in bronchopulmonary dysplasia: past, present, and future
Bryan G McOmber1, Alvaro G Moreira1, Kelsey Kirkman2
1Division of Neonatology, Department of Pediatrics, University Hospital, University of Texas Health Science Center at San Antonio, San Antonio, TX, United States.
Insights
Predictive analytics can improve management of bronchopulmonary dysplasia (BPD) in premature infants by analyzing large datasets to forecast outcomes. This approach offers personalized interventions for infants at risk of BPD.
Area of Science:
- Neonatal Medicine
- Data Science
- Bioinformatics
Background:
- Bronchopulmonary dysplasia (BPD) is a major complication of prematurity affecting 18,000 US infants annually.
- Despite advances in neonatal care, BPD incidence remains high, complicated by increased survival of extremely premature infants and practice variability.
Purpose of the Study:
- To review the application of predictive analytics in managing BPD.
- To explore data sources, modeling techniques, and evaluation metrics for BPD predictive models.
- To discuss the role of bioinformatics and machine learning in BPD risk prediction and prognosis.
Main Methods:
- Review of statistical and machine learning techniques for predictive analytics in BPD.
- Examination of commonly used clinical datasets and bioinformatics approaches.
- Analysis of case studies on machine learning for neonatal risk prediction.
Main Results:
- Predictive analytics can utilize large clinical datasets to forecast individual patient outcomes in BPD.
- Machine learning models show potential for risk prediction and prognosis in neonates with BPD.
- Bioinformatics may offer insights into the molecular underpinnings of BPD.
Conclusions:
- Predictive analytics offers a promising avenue for transforming neonatal care and enabling personalized interventions for infants at risk of BPD.
- Addressing challenges like data bias, model interpretability, and ethical considerations is crucial for successful integration.
- Future directions include enhancing model interpretability, data sharing, and aligning with precision medicine goals.
Abstract:
Bronchopulmonary dysplasia (BPD) remains a significant complication of prematurity, impacting approximately 18,000 infants annually in the United States. Advances in neonatal care have not reduced BPD, and its management is challenged by the rising survival of extremely premature infants and the variability in clinical practices. Leveraging statistical and machine learning techniques, predictive analytics can enhance BPD management by utilizing large clinical datasets to predict individual patient outcomes. This review explores the foundations and applications of predictive analytics in the context of BPD, examining commonly used data sources, modeling techniques, and metrics for model evaluation. We also highlight bioinformatics' potential role in understanding BPD's molecular basis and discuss case studies demonstrating the use of machine learning models for risk prediction and prognosis in neonates. Challenges such as data bias, model complexity, and ethical considerations are outlined, along with strategies to address these issues. Future directions for advancing the integration of predictive analytics into clinical practice include improving model interpretability, expanding data sharing and interoperability, and aligning predictive models with precision medicine goals. By overcoming current challenges, predictive analytics holds promise for transforming neonatal care and providing personalized interventions for infants at risk of BPD.
More Related Videos
06:15Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus
Published on: March 6, 2019
06:22Surfactant Depletion Combined with Injurious Ventilation Results in a Reproducible Model of the Acute Respiratory Distress Syndrome ARDS
Published on: April 7, 2021
Related Concept Videos
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Pulmonary Cycle: Exhalation
Pneumonia III: Complications and Assessment
Breathing
Pulmonary Function Tests
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...